Download PDF
Klin Monbl Augenheilkd 2010; 227(5): 393-399
DOI: 10.1055/s-0029-1245339
Übersicht

© Georg Thieme Verlag KG Stuttgart · New York

Amnionmembrantransplantation bei herpetischen Hornhautinfektionen

Amniotic Membrane Transplantation in Herpetic Corneal InfectionsD. Meller1 , H. Thomasen1 , K. Steuhl1
  • 1Zentrum für Augenheilkunde, Klinik für Erkrankungen des vorderen Augenabschnitts, Universität Duisburg-Essen
Further Information

Publication History

Eingegangen: 20.2.2010

Angenommen: 2.3.2010

Publication Date:
20 May 2010 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Schwere infektiöse Hornhautulzerationen, unter anderem mit herpetischer Genese, führen in der Regel zur deutlichen Beeinträchtigung der Sehschärfe bis hin zur Erblindung. Die Behandlung richtet sich nach der Grunderkrankung und erfordert neben einer breiten medikamentösen Therapie die Entwicklung chirurgischer Strategien zur Wiederherstellung der Integrität der kornealen Augenoberfläche. Herpetisch bedingte persistierende Hornhautepitheldefekte mit oder ohne Ulzeration bis hin zur Entwicklung einer neurotrophen Keratopathie mit dem Risiko der Perforation der Hornhaut stellen immer noch eine klinische Herausforderung in der Ophthalmochirurgie dar. Seit Einführung moderner Konservierungsmethoden Mitte der 1990er-Jahre hat die unter sterilen Bedingungen nach Kaiserschnitt gewonnene innerste Schicht der Plazenta, die Amnionmembran (AM) als Basalmembranersatz eine Renaissance erlebt und ist heute in der rekonstruktiven Chirurgie der Augenoberfläche kaum wegzudenken. Die vielfältigen, mittlerweile etablierten Einsatzmöglichkeiten der AM reichen von einem Transplantat („Graft”), natürlichen Verband („Patch”) bis hin zum Kultursubstrat („Carrier”) für die Ex-vivo-Züchtung von okulärem Oberflächenepithel. In diesem Übersichtsartikel sollen die Grundlagen und die klinische Applikation der Amnionmembrantransplantation (AMT) in der Behandlung von Hornhautinfektionen durch Herpes-Simplex-Virus und Varizella-Zoster-Virus beschrieben werden.

Abstract

Severe infectious corneal ulceration such as herpetic stromal keratitis commonly causes loss of vision and may lead to blindness. Treatment depending on the underlying disease includes antimicrobial medication and the development of surgical strategies to restore the integrity of the corneal ocular surface. Ulcerative herpetic stromal keratitis and/or neurotrophic keratopathy with the risk of corneal perforation are still clinically challenging conditions in ophthalmic surgery of the ocular surface. Since the introduction of newly developed preservation methods, amniotic membrane (AM) functioning as a basement membrane substitute has gained widespread popularity in ocular surface reconstruction. Various ways of clinical application such as the use of AM as a graft, patch or culture substrate and carrier system to expand ocular surface epithelia have been recently reported. In this article, the basis and clinical application of amniotic membrane transplantation for the management of corneal infections with Herpes simplex and Herpes zoster virus are reviewed.

Schlüsselwörter

Amnionmembran - Kornea - herpetische stromale Keratitis - Ulkus

Key words

amniotic membrane - cornea - herpetic stromal keratitis - ulcurs

Literatur

  • 1 DeRotth A. Plastic repair of conjunctival defects with fetal membrane.  Arch Ophthalmol. 1940;  40 522-525
    Google Scholar
  • 2 Lee S H, Tseng S C. Amniotic membrane transplantation for persistent epithelial defects with ulceration.  Am J Ophthalmol. 1997;  123 303-312
    Google Scholar
  • 3 Prabhasawat P, Barton K, Burkett G et al. Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision.  Ophthalmology. 1997;  104 974-985
    Google Scholar
  • 4 Kim J C, Tseng S C. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas.  Cornea. 1995;  14 473-484
    Google Scholar
  • 5 Meller D, Tseng S C. Reconstruction of the conjunctival and corneal surface. Transplantation of amnionic membrane.  Ophthalmologe. 1998;  95 805-813
    Google Scholar
  • 6 Tseng S C. Amniotic membrane transplantation for ocular surface reconstruction.  Biosci Rep. 2001;  21 481-489
    Google Scholar
  • 7 Prabhasawat P, Tseng S C. Impression cytology study of epithelial phenotype of ocular surface reconstructed by preserved human amniotic membrane.  Arch Ophthalmol. 1997;  115 1360-1367
    Google Scholar
  • 8 Kruse F E, Joussen A M, Rohrschneider K et al. Cryopreserved human amniotic membrane for ocular surface reconstruction.  Graefes Arch Clin Exp Ophthalmol. 2000;  238 68-75
    Google Scholar
  • 9 Thomasen H, Pauklin M, Steuhl K P et al. Comparison of cryopreserved and air-dried human amniotic membrane for ophthalmologic applications.  Graefes Arch Clin Exp Ophthalmol. 2009;  247 1691-1700
    Google Scholar
  • 10 Versen-Hoeynck von F, Steinfeld A P, Becker J et al. Sterilization and preservation influence the biophysical properties of human amnion grafts.  Biologicals. 2008;  36 248-255
    Google Scholar
  • 11 Meller D, Tseng S C. Conjunctival epithelial cell differentiation on amniotic membrane.  Invest Ophthalmol Vis Sci. 1999;  40 878-886
    Google Scholar
  • 12 Koizumi N J, Inatomi T J, Sotozono C J et al. Growth factor mRNA and protein in preserved human amniotic membrane.  Curr Eye Res. 2000;  20 173-177
    Google Scholar
  • 13 Kurpakus-Wheater M. Laminin-5 is a component of preserved amniotic membrane.  Curr Eye Res. 2001;  22 353-357
    Google Scholar
  • 14 Shimmura S, Shimazaki J, Ohashi Y et al. Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders.  Cornea. 2001;  20 408-413
    Google Scholar
  • 15 Solomon A, Rosenblatt M, Monroy D et al. Suppression of interleukin 1alpha and interleukin 1beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix.  Br J Ophthalmol. 2001;  85 444-449
    Google Scholar
  • 16 Ueta M, Kweon M N, Sano Y et al. Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction.  Clin Exp Immunol. 2002;  129 464-470
    Google Scholar
  • 17 Heiligenhaus A, Li H, Hernandez Galindo E E et al. Management of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation.  Br J Ophthalmol. 2003;  87 1215-1219
    Google Scholar
  • 18 Shi W Y, Chen M, Wang F H et al. Multilayer amniotic membrane transplantation for treatment of necrotizing herpes simplex stromal keratitis.  Zhonghua Yan Ke Za Zhi. 2005;  41 1107-1111
    Google Scholar
  • 19 Heiligenhaus A, Bauer D, Meller D et al. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation.  Invest Ophthalmol Vis Sci. 2001;  42 1969-1974
    Google Scholar
  • 20 Hao Y, Ma D H, Hwang D G et al. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane.  Cornea. 2000;  19 348-352
    Google Scholar
  • 21 Park W C, Tseng S C. Modulation of acute inflammation and keratocyte death by suturing, blood, and amniotic membrane in PRK.  Invest Ophthalmol Vis Sci. 2000;  41 2906-2914
    Google Scholar
  • 22 Heiligenhaus A, Li H, Yang Y et al. Amniotic membrane transplantation improves experimental herpetic keratitis. Modulation of matrix metalloproteinase-9.  Ophthalmologe. 2004;  101 59-65
    Google Scholar
  • 23 Bauer D, Wasmuth S, Hermans P et al. On the influence of neutrophils in corneas with necrotizing HSV-1 keratitis following amniotic membrane transplantation.  Exp Eye Res. 2007;  85 335-345
    Google Scholar
  • 24 Bauer D, Wasmuth S, Hennig M et al. Amniotic membrane transplantation induces apoptosis in T lymphocytes in murine corneas with experimental herpetic stromal keratitis.  Invest Ophthalmol Vis Sci. 2009;  50 3188-3198
    Google Scholar
  • 25 He H, Li W, Chen S Y et al. Suppression of activation and induction of apoptosis in RAW264.7 cells by amniotic membrane extract.  Invest Ophthalmol Vis Sci. 2008;  49 4468-4475
    Google Scholar
  • 26 Meller D, Pires R T, Mack R J et al. Amniotic membrane transplantation for acute chemical or thermal burns.  Ophthalmology. 2000;  107 980-989 ; discussion 990
    Google Scholar
  • 27 Shammas M C, Lai E C, Sarkar J S et al. Management of acute Stevens-Johnson syndrome and toxic epidermal necrolysis utilizing amniotic membrane and topical corticosteroids.  Am J Ophthalmol. 2010;  149 203-213 e202
    Google Scholar
  • 28 Sippel K C, Ma J J, Foster C S. Amniotic membrane surgery.  Curr Opin Ophthalmol. 2001;  12 269-281
    Google Scholar
  • 29 Seitz B, Gruterich M, Cursiefen C et al. Conservative and surgical treatment of neurotrophic keratopathy.  Ophthalmologe. 2005;  102 15-26
    Google Scholar
  • 30 Seitz B. Amniotic membrane transplantation. An indispensable therapy option for persistent corneal epithelial defects.  Ophthalmologe. 2007;  104 1075-1079
    Google Scholar
  • 31 John T, Foulks G N, John M E et al. Amniotic membrane in the surgical management of acute toxic epidermal necrolysis.  Ophthalmology. 2002;  109 351-360
    Google Scholar
  • 32 Meller D, Pires R T, Tseng S C. Ex vivo preservation and expansion of human limbal epithelial stem cells on amniotic membrane cultures.  Br J Ophthalmol. 2002;  86 463-471
    Google Scholar
  • 33 Seitz B, Das S, Sauer R et al. Amniotic membrane transplantation for persistent corneal epithelial defects in eyes after penetrating keratoplasty.  Eye. 2009;  23 840-848
    Google Scholar
  • 34 Kruse F E, Rohrschneider K, Volcker H E. Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers.  Ophthalmology. 1999;  106 1504-1510 ; discussion 1511
    Google Scholar
  • 35 Shi W, Chen M, Xie L. Amniotic membrane transplantation combined with antiviral and steroid therapy for herpes necrotizing stromal keratitis.  Ophthalmology. 2007;  114 1476-1481
    Google Scholar
  • 36 Knickelbein J E, Hendricks R L, Charukamnoetkanok P. Management of herpes simplex virus stromal keratitis: an evidence-based review.  Surv Ophthalmol. 2009;  54 226-234
    Google Scholar
  • 37 Spelsberg H, Reichelt J A. Amniotic membrane transplantation in proven ulcerative herpetic keratitis: successful anti-inflammatory treatment in time.  Klin Monbl Augenheilkd. 2008;  225 75-79
    Google Scholar
  • 38 Fuchsluger T, Tuerkeli E, Westekemper H et al. Rate of epithelialisation and re-operations in corneal ulcers treated with amniotic membrane transplantation combined with botulinum toxin-induced ptosis.  Graefes Arch Clin Exp Ophthalmol. 2007;  245 955-964
    Google Scholar
  • 39 Ferreira De Souza R, Hofmann-Rummelt C, Kruse F E et al. Multilayer amniotic membrane transplantation for corneal ulcers not treatable by conventional therapy – a prospective study of the status of cornea and graft during follow-up.  Klin Monbl Augenheilkd. 2001;  218 528-534
    Google Scholar
  • 40 Seitz B, Kruse F E. Neurotrophic keratitis. Problem child among corneal diseases.  Ophthalmologe. 2005;  102 5-6
    Google Scholar
  • 41 Bonini S, Lambiase A, Rama P et al. Topical treatment with nerve growth factor for neurotrophic keratitis.  Ophthalmology. 2000;  107 1347-1351 ; discussion 1351 – 1342
    Google Scholar
  • 42 Lambiase A, Manni L, Bonini S et al. Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas.  Invest Ophthalmol Vis Sci. 2000;  41 1063-1069
    Google Scholar
  • 43 You L, Kruse F E, Volcker H E. Neurotrophic factors in the human cornea.  Invest Ophthalmol Vis Sci. 2000;  41 692-702
    Google Scholar
  • 44 Marfurt C F, Murphy C J, Florczak J L. Morphology and neurochemistry of canine corneal innervation.  Invest Ophthalmol Vis Sci. 2001;  42 2242-2251
    Google Scholar
  • 45 Nagano T, Nakamura M, Nakata K et al. Effects of substance P and IGF-1 in corneal epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy.  Invest Ophthalmol Vis Sci. 2003;  44 3810-3815
    Google Scholar
  • 46 Nakamura M, Kawahara M, Nakata K et al. Restoration of corneal epithelial barrier function and wound healing by substance P and IGF-1 in rats with capsaicin-induced neurotrophic keratopathy.  Invest Ophthalmol Vis Sci. 2003;  44 2937-2940
    Google Scholar
  • 47 Gris O, Guell J L, Lopez-Navidad A et al. Application of the amniotic membrane in ocular surface pathology.  Ann Transplant. 1999;  4 82-84
    Google Scholar
  • 48 Prabhasawat P, Tesavibul N, Komolsuradej W. Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation.  Br J Ophthalmol. 2001;  85 1455-1463
    Google Scholar
  • 49 Chen H J, Pires R T, Tseng S C. Amniotic membrane transplantation for severe neurotrophic corneal ulcers.  Br J Ophthalmol. 2000;  84 826-833
    Google Scholar
  • 50 Schroeder A, Theiss C, Steuhl K P et al. Effects of the human amniotic membrane on axonal outgrowth of dorsal root ganglia neurons in culture.  Curr Eye Res. 2007;  32 731-738
    Google Scholar
  • 51 Touhami A, Grueterich M, Tseng S C. The role of NGF signaling in human limbal epithelium expanded by amniotic membrane culture.  Invest Ophthalmol Vis Sci. 2002;  43 987-994
    Google Scholar
  • 52 Tseng S C, Tsubota K. Important concepts for treating ocular surface and tear disorders.  Am J Ophthalmol. 1997;  124 825-835
    Google Scholar

Prof. Dr. Daniel Meller

Zentrum für Augenheilkunde, Klinik für Erkrankungen des vorderen Augenabschnitts, Universität Duisburg-Essen

Hufelandstraße 55

45122 Essen

Phone: ++ 49/7 23/8 43 82

Fax: ++ 49/7 23/56 45

Email: Daniel.Meller@uk-essen.de